Since 1991, the Hepatitis B Foundation has made tremendous strides forward in making hepatitis B history!
- HBF awarded a 5-year competitive cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC). The new CDC grant will support its work in continuing to build the national Hep B United coalition that it established in 2012 in partnership with AAPCHO to increase screening and linkage to care rates.
- HBF launched the 'HepDConnect.org' web-based program to increase awareness and provide information and support to those affected by this deadly virus, which only infects those already infected with hepatitis B. Visit hepdconnect.org
- HBF completed its two-year Patient Empowerment program in Haimen City, China that included more than 1,200 people chronically infected with hepatitis B who were identified in the first phase of our "Gateway to Care" campaign. Both phases were funded in part by the BMS Foundation and Haimen City CDC.
- HBF partnered with the Vietnam Viral Hepatitis Alliance (V-VHA) to launch a pilot a hepatitis B screening and care program in Ho Chi Minh City that has resulted in significant new funds to scale up the program. HBF medical director Dr. Robert Gish serves on the V-VHA board and is actively involved in Vietnam.
- HBF expanded its training programs with a Masters in Biomedical Sciences in collaboration with Geisinger Commonwealth College of Medicine, and a 6-week summer internship offered to high school students from China in partnership with the Philadelphia International Education Program.
- HBF's Baruch S. Blumberg Institute recruited world-renowned cancer physician scientist, Dr. Richard G. Pestell, to join its faculty. Dr. Pestell will create and lead the Cancer and Regenerative Medicine Research Center at the Blumberg Institute.
- HBF's Baruch S. Blumberg Institute scientists continue to be at the forefront of drug discovery for hepatitis B and liver cancer, as well as early detection biomarkers for primary liver cancer, the deadliest outcome of a chronic hepatitis B infection.
- The hepatitis B virus turns 50 this year! In February 1965, the Journal of the American Association (JAMA) published the first article about the Australia Antigen (now known has hepatitis B virus) by Drs. Baruch Blumberg, Harvey Alter and Sam Visnich. Dr. Blumberg won the Nobel Prize for his discovery
- HBF completes its first major gifts campaign A Nobel Challenge and raises $3 million to fund its research institute, the Baruch S. Blumberg Institute, to pioneer new ways to treat hepatitis B and liver cancer, the deadliest outcome of hepatitis B.
- HBF’s Baruch S. Blumberg Institute recruits 5 new internationally recognized scientists to work exclusively on hepatitis B research, which brings the total faculty and research staff to almost 50 people. This makes the Blumberg Institute the largest concentration of nonprofit scientists working on hepatitis B and liver cancer in the U.S.
- HBF outreach program reaches more than 1 million people from 200 countries through its hepb.org website; more than 6,000 people through email, phone and social media consults; and provides valuable information in 10 different languages.
- HBF completes publication of its Hepatitis B Screening and Monitoring Recommendations and Algorithm in the 5 major primary care medical journals ‒ J. American Academy of Physician Assistants (2014); J. Nurse Practitioners (2013); The Female Patient (2012); American J. of Medicine (2012); and the J. of Family Practice (2011)
- Hep B United, a national coalition created and led by HBF in partnership with AAPCHO since 2012, has grown to include 30 partners in 24 cities and 14 states across America with a collective reach to 4 million Asian Americans at increased risk for hepatitis B infection.
- HBF invited to join the international committee of experts to develop the World Health Organization’s first-ever published Management Guidelines for Hepatitis B.
- HBF’s Gateway to Care program in Haimen City, China reaches 1 million people. Results of the citywide public health campaign, supported in part by a competitive grant from the BMS Foundation, were published in BMC Public Health and presented at professional conferences.
- HBF renamed its research institute the Baruch S. Blumberg Institute in honor of Co-Founder Dr. Baruch Blumberg, who won the Nobel Prize for his discovery of the hepatitis B virus. For 20 years, Dr. Blumberg was a vital force in the development of the HBF and its research programs until his death in April 2011.
- HBF launched www.LiverCancerConnect.org, the first patient-focused website that provides information and support to those facing the challenge of primary liver cancer, which is the most serious consequence chronic hepatitis B.
- The Hep B United national coalition, created and co-chaired by HBF in partnership with AAPCHO, was approved for co-branding with the CDC’s first national Know Hepatitis B educational campaign.
- HBF successfully advocates for the rights of hepatitis B-infected individuals in the United States! Based on our reports to the CDC about many cases of institutional discrimination against hepatitis B infected healthcare workers and students, the CDC updated its recommendations to clearly state that hepatitis B should not prevent anyone from a healthcare career. These updated recommendations became the cornerstone of a landmark settlement by the U.S. Dept. of Justice on March 5, 2013 that officially recognizes hepatitis B as being protected under the Americans with Disabilities Act (ADA).
- HBF’s research institute represents the largest concentration of nonprofit scientists in the U.S. working on the problem of hepatitis B and liver cancer.
- To date, HBF’s research institute scientists are discovering new ways to attack the hepatitis B virus that could lead to promising new targets for drug discovery and an eventual cure.
- HBF established a new national coalition Hep B United in partnership with the Association for Asian and Pacific Community Health Organization (AAPCHO) to promote and leverage the success of community-based coalitions across the country in the fight against hepatitis B and liver cancer.
- HBF is helping to change clinical practice and national policy with published articles in peer-reviewed journals that highlight the underestimation and undertreatment of hepatitis B in the U.S., and the tremendous need to improve screening for this silent but deadly liver infection.
- Hepatitis B Foundation Celebrates 20th Anniversary
Watch the short YouTube video that captures the 20 year history of the Hepatitis B Foundation through old photos and interviews with the founders and Nobel Laureate Dr. Baruch Blumberg. View now!
- Merck & Co. donated its entire Natural Products Collection to the HBF’s research institute that provides access to a treasure trove for potential new therapies. As many as 50% of all medicines in use today came from natural products.
- A major American diagnostic company licensed the use to develop HBF’s HCC biomarker in the United States for the early detection of liver cancer; this same biomarker is already being used in China.
- HBF established its first international public health program in Haimen City, China to conduct a citywide hepatitis B education and outreach effort for the 1 million residents. This was made possible by a 3-year competitive grant from the BMS Foundation.
- Groundbreaking for nine new labs to accommodate the success of research entrepreneurs and a teaching lab for young scientists occurred in June.
- HBF was part of the IOM Report on Hepatitis and Liver Cancer from inception to fruition by providing testimony and having three of our medical advisors play a major role in this landmark report that set the stage for how the US will manage HBV and liver cancer in the next decade.
- HBF was at the forefront in working with Congressional members to advocate for HR 3974, the Hepatitis and Liver Cancer Prevention and Control Act 2009, a comprehensive bill that addresses the needs of more than five million Americans living with chronic hepatitis B.
- The highly competitive GSK IMPACT Award and $40,000 cash prize was awarded to the HBF for its comprehensive Outreach Program that helps improve access to care.
- John Ellis, a 17-year old cyclist from Florida took his devastating diagnosis of hepatitis B and turned it into an awareness campaign with his Believe in the Cure Cycling Tour of 1,287 miles from Pensacola to Philadelphia and raised $50,000 towards a cure!
- HBF convened the first National Pediatric Hepatitis B Workshop gathering an expert panel of pediatric liver specialists to discuss the management of children with chronic hepatitis B. Recommendations were published October 5, 2009 in Pediatrics.
- HBF organized a historic Library of Congress Symposium on HIV and HBV during National Hepatitis B Awareness Week to address the challenges in HIV vaccine development.
- Dr. Andy Cuconati, head of HBF’s Drug Discovery Program discovered a new compound that specifically suppresses release of HBV from infected liver cells.
- The Gateway to Care and the Philadelphia Task Force on Hepatitis B was launched to improve access to care through education and free screenings.
- HBF becomes sponsor of International HBV Meeting.
- HBF High School Science Enrichment Program is established.
- HBF opens its new Pennsylvania Biotechnology Center of Bucks County, created and owned in partnership with Delaware Valley College.
- HBF provides impetus for historic advocacy successes: First-ever National HBV Act introduced in Congress; first Congressional Briefing on HBV; and first National HBV Awareness Week in May called for by Congress.
- HBF establishes the Institute for Hepatitis and Virus Research (now the Baruch S. Blumberg Institute), which houses the HBF labs.
- HBF and University of Oxford Training Program is created - one of the first of its kind in the United States.
- Drexel University becomes the new academic partner of the HBF.
- Pennsylvania Governor Mark Schweiker presents a check for $7.9 million to HBF and Delaware Valley College to build a biotechnology research complex.
- HBF becomes a charter member of the National Viral Hepatitis Roundtable in Washington, D.C.
- HBF receives a $400,000 National Institutes of Health (NIH) grant to fund a total reconstruction of its website - www.hepb.org.
- HBF celebrates our 10th Anniversary!
- The "Bruce Witte Research Fellowship" is established to fund a young scientist pursuing hepatitis B research.
- College summer research internship program is established
- 6th Annual Princeton Workshop identifies "National Research Priorities for hepatitis B".
- $1.5 million PA state grant is received to support HBF outreach efforts, promote hepatitis research, and to conduct statewide viral hepatitis trainings.
- HBF offices and labs move under one roof to the new Jefferson Center for Biomedical Research, Doylestown, PA
- HBF outreach campaign results in PA Governor Tom Ridge declaring the first Hepatitis Awareness Month.
- O'Liver, the HBF liver mascot, makes its debut in a televised press conference on the Capitol in Harrisburg, PA
- HBF partners with Jefferson Medical College and Delaware Valley College to help establish a new research center in Doylestown, PA
- The first official HBF office is opened in Jenkintown, PA
- HBF goes on-line, creates a website (www.hepb.org) and is flooded with e-mails from around the world.
- Many new educational materials are developed to respond to the increasing requests for information.
- HBF advocacy efforts result in PA legislature passing Act 15 that adds the hepatitis B vaccine to the list of immunizations required for school entry.
- HBF invites 25 of the nation's leading scientists and clinicians to participate in the first Princeton Workshop, which is focused on hepatitis B therapeutic research.
- HBF reports that lamivudine is a promising new oral drug against hepatitis B.
- The HBF Research Lab is established at Jefferson Medical College, Philadelphia, PA.
- A PA state grant is received to produce two Emmy-nominated television Public Service Announcements to promote hepatitis B awareness.
- Drs. Timothy Block, Baruch Blumberg, and Raymond Dwek discover a new anti-HBV drug at Oxford University.
- A PA state grant received to produce HBF video, "Someone You Know Has Hepatitis B", which includes an introduction by Dr. Nancy Snyderman of Good Morning America.
- The B Informed Newsletter is launched.
- HBF incorporates as a 501(c)(3) nonprofit organization.
- First public HBF fundraiser in New Hope, PA raises $17,000.
- PA State Senator Jim Greenwood introduces the Hepatitis B Prevention, Research and Treatment Act into legislature.
- HBF reports that interferon alpha, an injectable drug, shows promise against hepatitis B.